Nifty Pharma dropped 0.66% at intraday as it underperformed benchmark Nifty 50 which dropped 0.46% at intraday.

Elara Capital observes that Aurobindo Pharma has 14 biosimilars in the pipeline. The company has also filed 3 biosimilars for ...

Aurobindo Pharma USA will acquire Lannett from Lannett Seller Holdco for $250 million on a cash-free, debt-free basis.

Recent hiccups related to manufacturing plant issues and tariff uncertainties have led to volatility in earnings and, ...

Motilal Oswal is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1300 in its ...

Here is the complete list of stocks that will remain in focus today as they trade ex-dividend on August 8, along with their ...

Prabhudas Lilladher is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1300 in ...

Several companies like Ceat and Indian Oil will trade ex-dividend from August 8, 2025. These companies recently announced ...

In a market overshadowed by US tariff threats and a tumbling rupee, cautious trading is essential. This article outlines the ...

Indian pharmaceutical stocks traded under pressure on Wednesday after US President Donald Trump said he would sharply raise ...

Shriram Life Insurance is strategically expanding its focus on annuity and pension products, anticipating a significant ...